$DOCS

Doximity insider Sitaram executed and sold portions of $4.12 options and had RSU withholding in August, described as routine. The article links a higher GAAP effective tax rate (about 40% vs 17% a year earlier) to equity-compensation taxation, contributing to GAAP EPS $0.13 vs non-GAAP $0.29. It also notes AI search revenue was not recognized in the June quarter, with gross margin 87.5% vs 91.2%.

After July Producer Price Index came in flat month over month, below expectations, and earlier CPI showed 0.1% monthly growth with annual inflation cooling to 3.4%, several software stocks rose. The article cites Rapid7 (RPD) up 3.6%, Tenable (TENB) up 3.2%, Marqeta (MQ) up 1.1%, Doximity (DOCS) up 0.3%, and 8x8 (EGHT) up 0.2%.

Doximity (DOCS) reported Q1 2027 revenue of $156.6 million, up 7% year over year, and adjusted EBITDA of $74.8 million. The company raised full-year 2027 revenue guidance to $671 million to $681 million. It said AI workflow and scribe usage grew, repurchased $91.6 million of stock, and ended June 30 with $688 million in cash and marketable securities.

Doximity (NYSE:DOCS) reported Q1 revenue of $156.62M, up from $145.91M, but net income fell to $24.32M from $53.32M. The company guided for Q2 revenue of $170–$171M and full-year revenue of $671–$681M, citing AI clinical tool adoption and enterprise AI client wins.

Doximity (NYSE:DOCS) reported fiscal Q1 revenue of $156.6M, up 7% year over year, while GAAP net income fell to $24.3M. The company said workflow active prescribers grew over 30% YoY and AI Search queries rose more than 25% QoQ. It raised FY2027 revenue guidance to $671M-$681M. Analysts’ price targets range from $18 to $47.

Doximity (DOCS) reported Q1 FY2027 revenue of $156.6 million, up 7% year over year, with adjusted EBITDA of $74.8 million. The company raised full-year 2027 revenue guidance to $671 million to $681 million and adjusted EBITDA guidance to $309 million to $329 million. It also repurchased $91.6 million of stock and ended June 30 with $688 million cash and marketable securities.

Doximity (NYSE:DOCS) shares surged after its fiscal Q1 report on Aug. 7, rising to an intraday high near $40 and closing up 32.6% at $27.40, after CEO Jeffrey Tangney said its AI Search has unit economics generating over 10x its operating cost. Results showed 7% YoY revenue to $156.6M, EPS $0.29, but net income -54% and free cash flow -34%.

Truist Securities raised its Doximity (NYSE:DOCS) price target to $24 from $19 and kept a Hold rating after the stock rose 0.46% premarket. Truist projects fiscal 2027 revenue of $673M and adjusted EBITDA of $320M, and fiscal 2028 revenue of $716M and adjusted EBITDA of $347M. Doximity reported Q1 FY27 revenue of $156.6M vs $151.7M expected and slightly missed EPS.

After July PPI came in flat m/m and CPI showed 0.1% m/m with annual inflation cooling to 3.4%, several software stocks rose as markets priced a less aggressive Fed. Rapid7 (RPD) gained 3.6%, 8x8 (EGHT) 0.2%, Doximity (DOCS) 0.3%, Marqeta (MQ) 1.1%, and Tenable (TENB) 3.2%.

Morgan Stanley downgraded Apple (AAPL) to Underperform, citing supply-chain checks that Apple cancelled a 20th anniversary all-glass iPhone model; price target cut to $263.66 from $285.56. It upgraded HPE to Overweight, PT $69 (from $71), and NetApp to Equal Weight, PT $173 (from $137). Other analyst actions included upgrades to Qualcomm, SanDisk, Dick’s Sporting, and Everpure, plus downgrades to Teradata, Akamai, Doximity, and Spectrum Brands.